Device
Vitagel
Vitagel is a medical device with 4 clinical trials. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
200%(4 trials)
Terminated
2(50%)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (25.0%)
N/A3 (75.0%)
Trials by Status
completed250%
terminated250%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel)
NCT01230931
terminatednot_applicable
Vitagel Revision Total Knee Arthroplasty
NCT01923805
completednot_applicable
A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty
NCT01285024
completedphase_4
Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty
NCT01027286
Clinical Trials (4)
Showing 4 of 4 trials
NCT01230931Not Applicable
Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel)
NCT01923805Not Applicable
Vitagel Revision Total Knee Arthroplasty
NCT01285024Not Applicable
A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty
NCT01027286Phase 4
Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4